PV Management in 2025: The Era of Expanding Alternatives

agregó una foto Health

2025-11-16 13:07:52

Polycythemia Vera (PV), a chronic myeloproliferative neoplasm characterized by the uncontrolled overproduction of red blood cells (erythrocytosis), is currently at a critical inflection point. In 2025, the polycythemia vera treatment market is defined by fierce competition between established therapies and compelling novel candidates, suggesting a major paradigm shift in patient management is...

0 Commentarios 0 Acciones 49 Views 0 Vista previa